Skip to main content
Tech.euFundingExplorerBeta

Nara Capital

Investor profile

Venture capital

Nara Capital has backed 3 European tech companies across 4 funding rounds in 2023, joining rounds totalling €14M. Most active in Healthtech. Data as of Nov 2026.

Deals
4
distinct rounds
Companies
3
backed
Active span
2023
1 yr
Total round €
€14M
sum of rounds joined

Deals by year

distinct rounds / year
Nara Capital — deals by year — interactive chart.
Data table
Nara Capital — deals by year
20234

Top sectors

by deals
Nara Capital — top sectors — interactive chart.
Data table
Nara Capital — top sectors
Healthtech4

Stages

by deals
Nara Capital — stages — interactive chart.
Data table
Nara Capital — stages
Other2
Seed2

Countries

by deals
Nara Capital — countries — interactive chart.
Data table
Nara Capital — countries
Spain4

Co-investment network

shared rounds
Co-investment network — interactive chart.
Nara Capital — 4 dealsNara CapitalClave Capital — 4 shared deals · click to openClave CapitalNamarel Ventures — 2 shared deals · click to openNamarel VenturesWA4STEAM — 2 shared deals · click to openWA4STEAMCanterbury Scientific — 1 shared deals · click to openCanterbury ScientificCDTI — 1 shared deals · click to openCDTICDTI Innvierte — 1 shared deals · click to openCDTI InnvierteEuropean Innovation Council (EIC) — 1 shared deals · click to openEuropean Innovation Council (EIC)Inveready — 1 shared deals · click to openInvereadyInvivo Capital Partners — 1 shared deals · click to openInvivo Capital PartnersJosep Carreras Foundation — 1 shared deals · click to openJosep Carreras Foundation

Hover a node for shared-deal counts; click a co-investor to open its profile.

Best viewed on a larger screen.

Portfolio

top 30 by total round €
CompanyCountryRoundsTotal €
Onechain ImmunotherapeuticsSpain1€6.7M
MiMARK DiagnosticsSpain2€5.2M
InnitiusSpain1€1.8M

Biggest deals

top 10 by amount
CompanyStageAmountDate
Onechain ImmunotherapeuticsSeed€6.7M2023-06
MiMARK DiagnosticsSeed€4.2M2023-11
InnitiusOther€1.8M2023-02
MiMARK DiagnosticsOther€1.0M2023-06
← Back to investors